Eva Ciruelos
- Oncology top 0.2%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Co-authors
- Javier CortésMario CamponeJosé BaselgaAndreas SchneeweißSung‐Bae KimJungsil RoEmma ClarkSandra M. Swain
- Topics
- HER2/EGFR in Cancer Research (104 papers)Advanced Breast Cancer Therapies (100 papers)Cancer Treatment and Pharmacology (91 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Eva Ciruelos
201 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 5.3k
- Cancer Research 2.4k
- Pulmonary and Respiratory Medicine 2.3k
- Molecular Biology 1.5k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Eva Ciruelos
This map shows the geographic impact of Eva Ciruelos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Ciruelos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Ciruelos more than expected).
Fields of papers citing papers by Eva Ciruelos
This network shows the impact of papers produced by Eva Ciruelos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Ciruelos. The network helps show where Eva Ciruelos may publish in the future.
Co-authorship network of co-authors of Eva Ciruelos
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Ciruelos. A scholar is included among the top collaborators of Eva Ciruelos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Ciruelos. Eva Ciruelos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 16 | |
| 3 | 7 | |
| 4 | 8 | |
| 5 | 1 | |
| 6 | 10 | |
| 7 | 14 | |
| 8 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studybreakdown → | 204 |
| 9 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancerbreakdown → | 176 |
| 10 | 19 | |
| 11 | 4 | |
| 12 | 31 | |
| 13 | 12 | |
| 14 | 5 | |
| 15 | 12 | |
| 16 | 19 | |
| 17 | 47 | |
| 18 | 39 | |
| 19 | 10 | |
| 20 | Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studybreakdown → | 700 |
About Eva Ciruelos
Eva Ciruelos is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 208 papers that have together received 7.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (104 papers), Advanced Breast Cancer Therapies (100 papers) and Cancer Treatment and Pharmacology (91 papers). The work is most often cited by research in Oncology (5.3k citations), Cancer Research (2.4k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Eva Ciruelos has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Javier Cortés, Mario Campone, José Baselga, Andreas Schneeweiß, Sung‐Bae Kim, Jungsil Ro, Emma Clark, Sandra M. Swain, Mark Benyunes and Jean-Marc Ferrero. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.